Bird & Bird advised Nexstim on cooperation and investment agreements with Brainlab

International law firm Bird & Bird has successfully advised Nexstim Plc, a Finnish, globally operating growth-oriented medical technology company, on its cooperation agreement and investment agreement with Brainlab AG, a leading German developer of advanced medical technology solutions.

The cooperation agreement aims at the advancement of non-invasive brain mapping technologies, as well as the distribution of certain Nexstim products by Brainlab in the segment. 

In connection with the cooperation agreement, Brainlab and Nexstim have also agreed on a maximum of EUR 5,095,000 equity investment into Nexstim by Brainlab. 

Bird & Bird’s advisory team, consisting of partners Maria Carlsson, Laura Huomo, and Iina-Mari Supperi, along with Counsel Vuokko Rajamäki and associates Juliana Kliesch, Marla Melin and Rondy Stenman, provided comprehensive legal support for both the cooperation and investment agreements.

News & Deals

More News & Deals

Deal

Bird & Bird advises CDP Venture Capital on Series A investment into Naturbeads

Jan 20 2025

Read More

Deal

Bird & Bird advises Endeit Capital on its Series B investment in Nomupay

Jan 17 2025

Read More

News

Bird & Bird strengthens London IP team with new brand management partner

Jan 13 2025

Read More

News

Bird & Bird and Keep the Archipelago Tidy Association launch pro bono partnership

Jan 13 2025

Read More

Deal

Bird & Bird advises DANX Carousel with its German market entry

Jan 13 2025

Read More

Deal

Bird & Bird advised Biomemory on its €17 million fundraising round

Dec 23 2024

Read More